Stephanie Cox
Family · Fort Rucker, ALNPI 1578119921
Payments from drug & device makers
Across 193 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$408
- Novo Nordisk$338
- AbbVie$330
- Lilly USA, LLC$233
- Pfizer$173
- Amgen$165
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,91398%
- Other$522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 33 | $408 |
| Novo Nordisk | 29 | $338 |
| AbbVie | 16 | $330 |
| Lilly USA, LLC | 22 | $233 |
| Pfizer | 10 | $173 |
| Amgen | 10 | $165 |
| Boehringer Ingelheim | 9 | $138 |
| E.r. Squibb & Sons, L.L.C. | 1 | $127 |
| Bayer | 8 | $108 |
| Corium, LLC | 4 | $99 |
| GSK | 5 | $82 |
| Amarin Pharma, Inc. | 5 | $78 |
| AstraZeneca | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Sanofi-aventis U.S. LLC | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Corcept Therapeutics | 4 | $58 |
| Merck | 4 | $56 |
| Daiichi Sankyo Inc. | 2 | $41 |
| ANI Pharmaceuticals, Inc. | 2 | $32 |
| Grifols USA, LLC | 2 | $28 |
| Exact Sciences | 2 | $27 |
| Welch Allyn | 1 | $26 |
| Baxter Healthcare | 1 | $26 |
| Upsher-smith Laboratories LLC | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| GRT US Holding, Inc. | 1 | $14 |
| Recordati_rare_diseases_inc. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$127
How this compares
$2,965 in reported general payments places this provider in the 80th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 60 | $64,824 |
| MounjaroTirzepatide | 28 | $36,198 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $34,974 |
| JanuviaSitagliptin Phosphate | 18 | $27,260 |
| EliquisApixaban | 24 | $23,145 |
| TrulicityDulaglutide | 16 | $22,113 |
| JardianceEmpagliflozin | 17 | $21,068 |
| MyrbetriqMirabegron | 23 | $20,002 |
| XareltoRivaroxaban | 11 | $17,083 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $16,980 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $14,215 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $12,989 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 19 | $10,685 |
| Potassium Chloride | 55 | $6,489 |
| Dexlansoprazole DrDexlansoprazole | 11 | $2,793 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $82 | $64,94378 claims |
| Novo NordiskOzempic | $338 | $64,82460 claims |
| Lilly USA, LLCMounjaro, Trulicity | $233 | $58,31144 claims |
| MerckJanuvia, Janumet, Janumet Xr | $56 | $52,16048 claims |
| PfizerEliquis | $173 | $23,14524 claims |
| Boehringer IngelheimJardiance | $138 | $21,06817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,415 family providers in Alabama.
Other family in Fort Rucker
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
- Brandy YoungMontgomery$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.